Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanjeev Pandya Insider Profile
4 Followers
Sanjeev Pandya, Executive Vice-President - Development at Advanced Oncotherapy, holds 125.00K shares in ImmuPharma (Ticker: GB:IMM), holds 58.62K shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Sanjeev Pandya Bought ― shares of ImmuPharma on Aug 24, 2021 for an estimated value of 10.00K.
Sanjeev Pandya Advanced Oncotherapy (AVO)Executive Vice-President - Development
Advanced Oncotherapy (AVO)
Executive Vice-President - Development
Ranked #7,560 out of 98,743 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+74.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sanjeev Pandya holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 17, 2014 - Apr 17, 2015
Return:+418.10%
The most profitable trade made by Sanjeev Pandya
Sanjeev Pandya's Trading History
Advanced Oncotherapy
Nov 08, 2016
Executive Vice-President - Development
Informative Buy
35.00K
£1.03K
ImmuPharma
Aug 24, 2021
Director
Informative Buy
10.00K
£2.59K
List of latest transactions for each holding click on a transaction to see Sanjeev Pandya's performance on stock
You May Also Like
Sanjeev Pandya insider profile FAQ
What is the percentage of profitable transactions made by Sanjeev Pandya?
The percentage of profitable transactions made by Sanjeev Pandya is 25%.
What is the average return per transaction made by Sanjeev Pandya?
The average return per transaction made by Sanjeev Pandya is 74.80%.
What stocks does Sanjeev Pandya hold?
Sanjeev Pandya holds: GB:AVO, GB:IMM stocks.
What was Sanjeev Pandya’s latest transaction?
Sanjeev Pandya latest transaction was an Informative Buy of 10.00K.
What was Sanjeev Pandya's most profitable transaction?
Sanjeev Pandya’s most profitable transaction was an Informative Buy of GB:AVO stock on April 17, 2014. The return on the trade was 418.10%.
What is Sanjeev Pandya's role in Advanced Oncotherapy?
Sanjeev Pandya's role in Advanced Oncotherapy is Executive Vice-President - Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.